Hypertension, or high blood pressure, is a chronic disease, which can occur early in life, and may lead to other cardiovascular disorders later if not treated. Until recently, hypertension was only directly associated with an increased risk of stroke-related illness. However, it is now known that poor blood pressure control also results in an increased risk of cardiovascular disease in general. Reports have estimated that in uncontrolled or hypertensive patients, 80% of the added risk is for cor
Conditions
Interventions
Daily consumption of a single dose of either egg white hydrolysate or placebo over six weeks. After a six weeks of wash out the six week cross-over treatment will be consumed.
Sponsors
Bio-Actor BVBA
Technologiepark 3
9052 Gent
Belgium
Eligibility
Inclusion criteria
Inclusion criteria: 1. Blood pressure >130 mm Hg (systolic) and >80 mm Hg (diastolic) 2. Not taking any concomitant medication 3. Otherwise healthy 4. Alcohol consumption <14 units/week for women and <21 units/week for men 5. Aged 35-70 years
Exclusion criteria
Exclusion criteria: 1. Participation in any other clinical trial including blood sampling and/or administration of substances up to 90 days before day 1 of this study. 2. Mental status that is incompatible with the proper conduct of the study. 3. Reported unexplained weight loss or gain (>2 kg) in the last month before screening. 4. Females who are pregnant/lactating or planning to become pregnant during the study period. 5. Have a proven allergy toward egg derived products.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To establish a significant blood pressure reduction by providing subjects with supplements of an egg white hydrolysate. | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect on serum cholesterol levels | — |
Contacts
Public ContactHans Saag, van der
Technologiepark 3
Outcome results
None listed